Tenofovir Drug Combination Rilpivirine Emtricitabine

A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.

Also Known As:

Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Complera; Emtricitabine Rilpivirine Tenofovir Drug Combination; Emtricitabine-Rilpivirine-Tenofovir Drug Combination; Combination, Emtricitabine-Rilpivirine-Tenofovir Drug; Drug Combination, Emtricitabine-Rilpivirine-Tenofovir

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Boven, Katia: 1 article (04/2013)
2.	Buelens, Annemie: 1 article (04/2013)
3.	Crauwels, Herta: 1 article (04/2013)
4.	Hoetelmans, Richard: 1 article (04/2013)
5.	Stevens, Marita: 1 article (04/2013)
6.	Vanveggel, Simon: 1 article (04/2013)
7.	van Heeswijk, Rolf P G: 1 article (04/2013)

Related Diseases

1.	Infections 04/01/2013 - "Rilpivirine (TMC278) is a non-nucleoside reverse transcriptase inhibitor approved in combination with other antiretrovirals for the treatment of HIV-1 infection in treatment-naive adults (Edurant(®) 25 mg once daily; Complera(®) [USA]/Eviplera(®) [EU] once daily single-tablet regimen). "

Related Drugs and Biologics

1.	Reverse Transcriptase Inhibitors
2.	Tablets
3.	Nucleosides
4.	Rilpivirine (TMC-278)